Phimchanok Sakunpongpitiporn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Phimchanok Sakunpongpitiporn has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Anuvat Sirivat
The Petroleum and Petrochemical College, Chulalongkorn University, Bangkok 10330, Thailand
12 shared publications Rawita Morarad
Conductive and Electroactive Polymers Research Unit, The Petroleum and Petrochemical College, Chulalongkorn University, Bangkok 10330, Thailand
6 shared publicationsKatesara Phasuksom
4 shared publicationsNophawan Paradee
Conductive and Electroactive Polymers Research Unit, The Petroleum and Petrochemical College, Chulalongkorn University, Bangkok 10330, Thailand
4 shared publicationsSumonman Niamlang
Department of Materials and Metallurgical Engineering, Faculty of Engineering, Rajamangala University of Technology Thanyaburi, Pathumthani, 12110, Thailand
3 shared publications- Sumonman Niamlang
Department of Materials and Metallurgical Engineering, Faculty of Engineering, Rajamangala University of Technology Thanyaburi (RMUTT), Pathum Thani, Thailand
3 shared publications
Latest Publications
- Open Access
A Robust Current-Feedback Operational Amplifier-Based Front-End Amplifier for Electrocardiogram Signal Noise Removal
This paper introduces an electrocardiogram (ECG) noise removal front-end amplifier circuit based on a current-feedback operational amplifier (CFOA) that uses the current feedback to detect error signals and control the output. This ECG circuit focuses on denoising the ECG noise to accentuate the ECG electrical signals from the heart. Noises in ECG refer to baseline wander (BW), powerline interference (PLI) and motion artifacts. We proposed a CFOA-based ECG pre-amplifier using the AD844 commercial operational amplifier built inside with a positive second-generation current conveyor (CCII+) and a voltage follower circuit. This work introduces an ECG noise removal front-end amplifier based on a CFOA. The primary innovation lies in the balancing instrumentation amplifier architecture that utilizes the high-speed and robust properties of the AD844 commercial operational amplifier to achieve superior noise rejection. To protect against high-frequency interference, we introduce a novel cascaded low-pass filter (LPF) stage that ensures a sharper cut-off compared to traditional single-stage designs. Experimental results validate the design’s effectiveness, achieving a high common-mode rejection ratio (CMRR) of 75.4 dB and a mid-band gain of 46.5 dB. These performance metrics, combined with the circuit’s ability to eliminate BW and PLI, confirm its robust suitability for high-fidelity wearable ECG monitoring.
Open AccessA Robust Current-Feedback Operational Amplifier-Based Front-End Amplifier for Electrocardiogram Signal Noise Removal
This paper introduces an electrocardiogram (ECG) noise removal front-end amplifier circuit based on a current-feedback operational amplifier (CFOA) that uses the current feedback to detect error signals and control the output. This ECG circuit focuses on denoising the ECG noise to accentuate the ECG electrical signals from the heart. Noises in ECG refer to baseline wander (BW), powerline interference (PLI) and motion artifacts. We proposed a CFOA-based ECG pre-amplifier using the AD844 commercial operational amplifier built inside with a positive second-generation current conveyor (CCII+) and a voltage follower circuit. This work introduces an ECG noise removal front-end amplifier based on a CFOA. The primary innovation lies in the balancing instrumentation amplifier architecture that utilizes the high-speed and robust properties of the AD844 commercial operational amplifier to achieve superior noise rejection. To protect against high-frequency interference, we introduce a novel cascaded low-pass filter (LPF) stage that ensures a sharper cut-off compared to traditional single-stage designs. Experimental results validate the design’s effectiveness, achieving a high common-mode rejection ratio (CMRR) of 75.4 dB and a mid-band gain of 46.5 dB. These performance metrics, combined with the circuit’s ability to eliminate BW and PLI, confirm its robust suitability for high-fidelity wearable ECG monitoring.
- Open Access
- 17 April 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (4) , 494
Transdermal Delivery of Sonidegib via Iontophoresis from PEDOT:PSS/Gelatin Hydrogels for Basal Cell Carcinoma Skin Cancer
Background/Objectives: Skin cancers belong to the most frequent cancer type with over a million cases per year. Presently, transdermal drug delivery systems (TDDS) are an attractive drug delivery route, but they still face some limitations due to the resistance of human skin. Methods: Here, Sonidegib, PEDOT:PSS, and gelatins were employed as the model drug, drug carrier, and drug matrix, respectively. Results: Gelatin hydrogels were fabricated via the physical crosslinking to avoid toxicity towards the human skin. PEDOT:PSS was synthesized by chemical oxidative polymerization as the drug carrier. Sonidegib first interacted with PEDOT:PSS before they were embedded into the gelatin hydrogels. In the release and release-permeation experiments, the amounts of Sonidegib released and permeated were investigated under the effects of gelatin types, concentrations, pH values, PEDOT:PSS, and electrical voltages. For the effect of gelatin types, the BG gelatin provided higher amounts of Sonidegib release than PG from the higher electrorepulsive force. Under applied electrical voltages and with PEDOT:PSS present, the amounts of Sonidegib release and release-permeation amounts increased as PEDOT:PSS assisted in providing higher electroosmosis and electrorepulsive forces. Conclusions: In summary, PEDOT:PSS in the BG hydrogel is demonstrated here as a potential drug carrier to improve the Sonidegib release and release-permeation iontophoretically for TDDS.
- 17 April 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (4) , 494
Open AccessTransdermal Delivery of Sonidegib via Iontophoresis from PEDOT:PSS/Gelatin Hydrogels for Basal Cell Carcinoma Skin Cancer
Background/Objectives: Skin cancers belong to the most frequent cancer type with over a million cases per year. Presently, transdermal drug delivery systems (TDDS) are an attractive drug delivery route, but they still face some limitations due to the resistance of human skin. Methods: Here, Sonidegib, PEDOT:PSS, and gelatins were employed as the model drug, drug carrier, and drug matrix, respectively. Results: Gelatin hydrogels were fabricated via the physical crosslinking to avoid toxicity towards the human skin. PEDOT:PSS was synthesized by chemical oxidative polymerization as the drug carrier. Sonidegib first interacted with PEDOT:PSS before they were embedded into the gelatin hydrogels. In the release and release-permeation experiments, the amounts of Sonidegib released and permeated were investigated under the effects of gelatin types, concentrations, pH values, PEDOT:PSS, and electrical voltages. For the effect of gelatin types, the BG gelatin provided higher amounts of Sonidegib release than PG from the higher electrorepulsive force. Under applied electrical voltages and with PEDOT:PSS present, the amounts of Sonidegib release and release-permeation amounts increased as PEDOT:PSS assisted in providing higher electroosmosis and electrorepulsive forces. Conclusions: In summary, PEDOT:PSS in the BG hydrogel is demonstrated here as a potential drug carrier to improve the Sonidegib release and release-permeation iontophoretically for TDDS.
- Open Access
- 26 September 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (43) , 35883-35891
Tuning polyaniline doped with poly(4-styrenesulfonic acid) (PANI : PSS) as a nano-drug carrier for insulin delivery
Polyaniline (PANI) is one of the most well-known conductive polymers, but it is not soluble in water. PSS, a polyelectrolyte and dopant, has demonstrated the ability to enhance both electrical conductivity and solubility in water. PANI : PSS were synthesized under the effect of polymerization times, oxidant (APS) ratios, and dopant (PSS) ratios. The suitable synthesized PANI : PSS was the ANI : APS mole ratio of 1 : 1 and ANI : PSS wt ratio of 1 : 5 for 24 h providing the highest electrical conductivity (6.84 x 10−2 ± 4.30 x 10−4 S cm−1) and still remained as nanoparticles (42.11 ± 7.41 nm). Insulin, a model drug, was ion-exchanged with PANI : PSS, replacing PSS. The amount of insulin loaded into PANI : PSS (insulin-PANI : PSS) was varied with weight ratios of 0.5 : 1, 1 : 1, and 3 : 1, with the 1 : 1 wt ratio exhibiting 96.4% loading efficiency. The synthesized PANI : PSS is demonstrated as a potential insulin carrier for transdermal drug delivery.
- 26 September 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (43) , 35883-35891
Open AccessTuning polyaniline doped with poly(4-styrenesulfonic acid) (PANI : PSS) as a nano-drug carrier for insulin delivery
Polyaniline (PANI) is one of the most well-known conductive polymers, but it is not soluble in water. PSS, a polyelectrolyte and dopant, has demonstrated the ability to enhance both electrical conductivity and solubility in water. PANI : PSS were synthesized under the effect of polymerization times, oxidant (APS) ratios, and dopant (PSS) ratios. The suitable synthesized PANI : PSS was the ANI : APS mole ratio of 1 : 1 and ANI : PSS wt ratio of 1 : 5 for 24 h providing the highest electrical conductivity (6.84 x 10−2 ± 4.30 x 10−4 S cm−1) and still remained as nanoparticles (42.11 ± 7.41 nm). Insulin, a model drug, was ion-exchanged with PANI : PSS, replacing PSS. The amount of insulin loaded into PANI : PSS (insulin-PANI : PSS) was varied with weight ratios of 0.5 : 1, 1 : 1, and 3 : 1, with the 1 : 1 wt ratio exhibiting 96.4% loading efficiency. The synthesized PANI : PSS is demonstrated as a potential insulin carrier for transdermal drug delivery.
- Open Access
- 3 January 2024
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 14 (3) , 1549-1562
Poly(3,4-ethylenedioxythiophene):polystyrene sulfonate (PEDOT:PSS) as an insulin carrier in silk fibroin hydrogels for transdermal delivery via iontophoresis
In this study, silk fibroin (SF) was utilized as the starting material to fabricate physically crosslinked hydrogels. Poly(3,4-ethylenedioxythiophene):polystyrene sulfonate (PEDOT:PSS) was synthesized and characterized as a drug carrier, with insulin as the model drug. PEDOT:PSS, with a high electrical conductivity of 1666 ± 49 S cm−1, interacted with insulin molecules via electrostatic interaction by replacing the dopant PSS molecules. Insulin-loaded PEDOT:PSS embedded in the SF hydrogel resulted in an increase in the degree of swelling, pore size, and mesh size of the hydrogel. In the in vitro release and release-permeation experiments, the amounts of insulin release and release-permeation were investigated using a modified Franz diffusion cell, under the effects of SF concentrations, electric fields, and pH values. The amounts of insulin release and release-permeation from the pristine SF hydrogel and the PEDOT:PSS/SF hydrogel followed the power laws with the scaling exponents close to 0.5, indicating the Fickian diffusion or the concentration gradient. Under electric fields, with or without PEDOT:PSS used as the drug carrier, the insulin amount and diffusion coefficient were shown to increase with the increasing electric field due to the electro-repulsive forces between the cathode and insulin molecules and SF chains, electroosmosis, and SF matrix swelling. The SF hydrogel and PEDOT:PSS as the drug carrier are demonstrated herein as new components in the transdermal delivery system for the iontophoretically controlled insulin basal release applicable to diabetes patients.
- 3 January 2024
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 14 (3) , 1549-1562
Open AccessPoly(3,4-ethylenedioxythiophene):polystyrene sulfonate (PEDOT:PSS) as an insulin carrier in silk fibroin hydrogels for transdermal delivery via iontophoresis
In this study, silk fibroin (SF) was utilized as the starting material to fabricate physically crosslinked hydrogels. Poly(3,4-ethylenedioxythiophene):polystyrene sulfonate (PEDOT:PSS) was synthesized and characterized as a drug carrier, with insulin as the model drug. PEDOT:PSS, with a high electrical conductivity of 1666 ± 49 S cm−1, interacted with insulin molecules via electrostatic interaction by replacing the dopant PSS molecules. Insulin-loaded PEDOT:PSS embedded in the SF hydrogel resulted in an increase in the degree of swelling, pore size, and mesh size of the hydrogel. In the in vitro release and release-permeation experiments, the amounts of insulin release and release-permeation were investigated using a modified Franz diffusion cell, under the effects of SF concentrations, electric fields, and pH values. The amounts of insulin release and release-permeation from the pristine SF hydrogel and the PEDOT:PSS/SF hydrogel followed the power laws with the scaling exponents close to 0.5, indicating the Fickian diffusion or the concentration gradient. Under electric fields, with or without PEDOT:PSS used as the drug carrier, the insulin amount and diffusion coefficient were shown to increase with the increasing electric field due to the electro-repulsive forces between the cathode and insulin molecules and SF chains, electroosmosis, and SF matrix swelling. The SF hydrogel and PEDOT:PSS as the drug carrier are demonstrated herein as new components in the transdermal delivery system for the iontophoretically controlled insulin basal release applicable to diabetes patients.
- 18 November 2023
- Published by Elsevier in European Polymer Journal
- Vol. 202
Polyindole:poly(4-styrenesulfonic acid) loaded agarose hydrogel for methotrexate sodium transdermal delivery via iontophoresis
- 18 November 2023
- Published by Elsevier in European Polymer Journal
- Vol. 202
Polyindole:poly(4-styrenesulfonic acid) loaded agarose hydrogel for methotrexate sodium transdermal delivery via iontophoresis
- 14 November 2022
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 223 (Pt A) , 702-712
Metformin delivery via iontophoresis based on κ-carrageenan cryogels
- 14 November 2022
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 223 (Pt A) , 702-712
Metformin delivery via iontophoresis based on κ-carrageenan cryogels
- Open Access
Synthesis of Highly Conductive Poly(3-hexylthiophene) by Chemical Oxidative Polymerization Using Surfactant Templates
Poly(3-hexylthiophene) (P3HT) was systematically synthesized by chemical oxidative polymerization in chloroform with ferric chloride (FeCl3) as the oxidizing agent and various surfactants of the shape templates. The effects of 3HT: FeCl3 mole ratios, polymerization times, and surfactant types and concentrations on the electrical conductivity, particle shape and size were systematically investigated. Furthermore, dodecylbenzenesulfonic acid (DBSA), p-toluenesulfonic acid (PTSA), sodium dodecyl sulfate (SDS), and sodium dioctyl sulfosuccinate (AOT) were utilized as the surfactant templates. The P3HT synthesized with DBSA at 6 CMC, where CMC stands for the Critical Micelle Concentration of surfactant, provided a higher electrical conductivity than those with PTSA, SDS and AOT. The highest electrical conductivity of P3HT using DBSA was 16.21 ± 1.55 S cm−1 in which the P3HT particle shape was spherical with an average size of 1530 ± 227 nm. The thermal analysis indicated that the P3HT synthesized with the surfactants yielded higher stability and char yields than that of P3HT without. The P3HT_DBSA electrical conductivity was further enhanced by de-doping and doping with HClO4. At the 10:1 doping mole ratio, the electrical conductivity of dP3HT_DBSA increased by one order of magnitude relative to P3HT_DBSA prior to the de-doping. The highest electrical conductivity of dP3HT_DBSA obtained was 172 ± 5.21 S cm−1 which is the highest value relative to previously reported.
Open AccessSynthesis of Highly Conductive Poly(3-hexylthiophene) by Chemical Oxidative Polymerization Using Surfactant Templates
Poly(3-hexylthiophene) (P3HT) was systematically synthesized by chemical oxidative polymerization in chloroform with ferric chloride (FeCl3) as the oxidizing agent and various surfactants of the shape templates. The effects of 3HT: FeCl3 mole ratios, polymerization times, and surfactant types and concentrations on the electrical conductivity, particle shape and size were systematically investigated. Furthermore, dodecylbenzenesulfonic acid (DBSA), p-toluenesulfonic acid (PTSA), sodium dodecyl sulfate (SDS), and sodium dioctyl sulfosuccinate (AOT) were utilized as the surfactant templates. The P3HT synthesized with DBSA at 6 CMC, where CMC stands for the Critical Micelle Concentration of surfactant, provided a higher electrical conductivity than those with PTSA, SDS and AOT. The highest electrical conductivity of P3HT using DBSA was 16.21 ± 1.55 S cm−1 in which the P3HT particle shape was spherical with an average size of 1530 ± 227 nm. The thermal analysis indicated that the P3HT synthesized with the surfactants yielded higher stability and char yields than that of P3HT without. The P3HT_DBSA electrical conductivity was further enhanced by de-doping and doping with HClO4. At the 10:1 doping mole ratio, the electrical conductivity of dP3HT_DBSA increased by one order of magnitude relative to P3HT_DBSA prior to the de-doping. The highest electrical conductivity of dP3HT_DBSA obtained was 172 ± 5.21 S cm−1 which is the highest value relative to previously reported.
- Open Access
- 18 July 2022
- Published by Taylor & Francis in Drug Delivery
- Vol. 29 (1) , 2234-2244
Enhanced transdermal insulin basal release from silk fibroin (SF) hydrogels via iontophoresis
Insulin is the peptide hormone used to treat the diabetes patient. The hormone is normally taken by injection. The transdermal drug delivery system (TDDS) is an alternative route. The silk fibroin (SF) hydrogels were fabricated via solution casting as the insulin matrix. The release and release-permeation experiments of the insulin loaded SF hydrogels were carried out using a modified Franz-diffusion cell at 37 °C for 36 h, under the effects of SF concentrations, pH, and electric field. The release-permeation mechanism through the pig skin was from the Case-II transport with the constant release rate. The diffusion coefficient (D) increased with decreasing SF concentration due to a larger mesh size, and with increasing electric field due to the electroreplusive forces between the insulin and the SF hydrogels against the negatively-charged electrode, and the induced SF hydrogel expansion. The rate and amount of insulin release-permeation became relatively lower as it required a longer time to generate aqueous pathways through the pig skin. The present SF hydrogels are demonstrated here deliver insulin with the required constant release rate, and the suitable amount within a prescribed duration.
- 18 July 2022
- Published by Taylor & Francis in Drug Delivery
- Vol. 29 (1) , 2234-2244
Open AccessEnhanced transdermal insulin basal release from silk fibroin (SF) hydrogels via iontophoresis
Insulin is the peptide hormone used to treat the diabetes patient. The hormone is normally taken by injection. The transdermal drug delivery system (TDDS) is an alternative route. The silk fibroin (SF) hydrogels were fabricated via solution casting as the insulin matrix. The release and release-permeation experiments of the insulin loaded SF hydrogels were carried out using a modified Franz-diffusion cell at 37 °C for 36 h, under the effects of SF concentrations, pH, and electric field. The release-permeation mechanism through the pig skin was from the Case-II transport with the constant release rate. The diffusion coefficient (D) increased with decreasing SF concentration due to a larger mesh size, and with increasing electric field due to the electroreplusive forces between the insulin and the SF hydrogels against the negatively-charged electrode, and the induced SF hydrogel expansion. The rate and amount of insulin release-permeation became relatively lower as it required a longer time to generate aqueous pathways through the pig skin. The present SF hydrogels are demonstrated here deliver insulin with the required constant release rate, and the suitable amount within a prescribed duration.